Real world data show that immunotherapy leads to better overall survival outcomes than chemotherapy in patients with ...

By leveraging multi-omics analysis and machine learning techniques, the research team led by Professor Shuo Wang (Institute ...

A new form of tumor infiltrating lymphocyte (TIL) therapy, a form of personalized cancer immunotherapy, dramatically improved the treatment's effectiveness in patients with metastatic gastrointestinal ...

Matejcic says. "We hope that our findings will contribute to improving the survival outcome of MSS colorectal cancer patients who are currently unresponsive to immunotherapy." More information ...

Bristol Myers Squibb (BMS) has announced that its dual immunotherapy combination has been approved by the US Food and Drug ...

US pharma major Bristol Myers Squibb has received full approval from the US Food and Drug Administration for the use of ...

The ROC analysis confirmed that IRRS outperformed TIDE in predicting immunotherapy response, with higher AUC values across all datasets. Notably, higher IRRS scores correlated with poorer survival ...

A team of researchers from the Rice Biotech Launch Pad at Rice University has developed an implantable "cytokine factory" ...

Learn about the early warning signs of colon cancer, lifestyle changes to lower your risk, and the importance of regular ...

Regulatory hurdles and the lengthy approval process for new therapies also pose significant challenges for market players. Emerging trends in the colorectal cancer market include the increasing ...